Darrin Beaupre - Mar 1, 2024 Form 4 Insider Report for IDEAYA Biosciences, Inc. (IDYA)

Role
Chief Medical Officer
Signature
/s/ Jason Throne, as Attorney-in-Fact for Darrin Beaupre
Stock symbol
IDYA
Transactions as of
Mar 1, 2024
Transactions value $
$0
Form type
4
Date filed
3/4/2024, 05:27 PM
Previous filing
Feb 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDYA Stock Option (right to buy) Award $0 +160K $0.00 160K Mar 1, 2024 Common Stock 160K $46.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.